Duality Advisers LP Makes New $192,000 Investment in agilon health, inc. (NYSE:AGL)

Duality Advisers LP purchased a new position in agilon health, inc. (NYSE:AGL) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 15,267 shares of the company’s stock, valued at approximately $192,000.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in AGL. CWM LLC increased its stake in shares of agilon health by 83.7% in the third quarter. CWM LLC now owns 1,585 shares of the company’s stock worth $28,000 after acquiring an additional 722 shares during the period. SG Americas Securities LLC increased its stake in shares of agilon health by 98.3% in the third quarter. SG Americas Securities LLC now owns 12,886 shares of the company’s stock worth $229,000 after acquiring an additional 6,389 shares during the period. Handelsbanken Fonder AB increased its stake in shares of agilon health by 28.8% in the third quarter. Handelsbanken Fonder AB now owns 42,000 shares of the company’s stock worth $746,000 after acquiring an additional 9,400 shares during the period. Harbor Capital Advisors Inc. increased its stake in shares of agilon health by 46.4% in the third quarter. Harbor Capital Advisors Inc. now owns 7,717 shares of the company’s stock worth $137,000 after acquiring an additional 2,445 shares during the period. Finally, Xponance Inc. increased its stake in shares of agilon health by 7.5% in the third quarter. Xponance Inc. now owns 37,685 shares of the company’s stock worth $669,000 after acquiring an additional 2,633 shares during the period.

agilon health Price Performance

agilon health stock opened at $5.00 on Friday. The company’s 50 day simple moving average is $5.55 and its 200-day simple moving average is $9.51. The company has a market capitalization of $2.05 billion, a price-to-earnings ratio of -7.68 and a beta of 0.49. agilon health, inc. has a 1 year low of $4.41 and a 1 year high of $26.75. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.51 and a current ratio of 1.51.

agilon health (NYSE:AGL) last released its quarterly earnings results on Tuesday, February 27th. The company reported ($0.41) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.28) by ($0.13). The company had revenue of $1.06 billion during the quarter, compared to analysts’ expectations of $1.02 billion. agilon health had a negative net margin of 5.76% and a negative return on equity of 21.74%. agilon health’s revenue was up 71.8% on a year-over-year basis. During the same period last year, the firm posted ($0.14) earnings per share. As a group, equities research analysts expect that agilon health, inc. will post -0.35 earnings per share for the current year.

Wall Street Analyst Weigh In

AGL has been the topic of several analyst reports. JPMorgan Chase & Co. lowered shares of agilon health from an “overweight” rating to a “neutral” rating and dropped their price target for the company from $17.00 to $9.00 in a research report on Friday, January 5th. Wolfe Research lowered shares of agilon health from an “outperform” rating to a “peer perform” rating in a research report on Monday, January 8th. TD Cowen lowered shares of agilon health from an “outperform” rating to a “market perform” rating and dropped their price target for the company from $12.00 to $6.50 in a research report on Monday, February 26th. Stifel Nicolaus dropped their price target on shares of agilon health from $10.00 to $9.00 and set a “hold” rating on the stock in a research report on Thursday, February 22nd. Finally, Barclays initiated coverage on shares of agilon health in a research report on Wednesday, March 6th. They set an “underweight” rating and a $5.00 price target on the stock. One equities research analyst has rated the stock with a sell rating, twelve have issued a hold rating and four have given a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $9.46.

agilon health Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.